NRx Pharmaceuticals, Inc. (NRXP) DCF Valuation

NRx Pharmaceuticals, Inc. (NRXP) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

NRx Pharmaceuticals, Inc. (NRXP) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify NRx Pharmaceuticals, Inc. (NRXP) valuation with this customizable DCF Calculator! Featuring real NRx Pharmaceuticals, Inc. (NRXP) financials and adjustable forecast inputs, you can test scenarios and uncover NRx Pharmaceuticals, Inc. (NRXP) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -.7 -51.7 -93.0 -39.8 -30.0 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -.7 -51.7 -93.0 -39.8 -30.0 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .0 1.9 27.6 20.1 4.6 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .8 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .2 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .6 3.2 3.7 2.1 4.6 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0.02984184 0.02984184 0.02984184 0.02984184 0.02984184 0.02984184 0.02984184 0.02984184 0.02984184 0.02984184
EBITAT -.6 -12.3 -71.7 -35.2 -30.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF .0 -10.8 -70.1 -36.8 -27.5 -4.6 .0 .0 .0 .0
WACC, % 7.44 6.27 7.33 7.55 7.78 7.28 7.28 7.28 7.28 7.28
PV UFCF
SUM PV UFCF -4.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -4
Net Debt 5
Equity Value -9
Diluted Shares Outstanding, MM 8
Equity Value Per Share -1.17

What You Will Get

  • Real NRXP Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Explore various scenarios to assess NRx Pharmaceuticals' future performance.
  • User-Friendly Design: Designed for professionals while remaining approachable for newcomers.

Key Features

  • Comprehensive Financial Data: Gain access to precise historical data and forward-looking projections for NRx Pharmaceuticals, Inc. (NRXP).
  • Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Engage with intuitive charts and summaries to clearly present your valuation findings.
  • Designed for All Skill Levels: A straightforward and accessible layout tailored for investors, CFOs, and consultants alike.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review NRx Pharmaceuticals, Inc.'s (NRXP) pre-filled financial data and forecasts.
  3. Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
  5. Step 5: Evaluate the outputs and leverage the results for your investment strategies.

Why Choose NRx Pharmaceuticals, Inc. (NRXP)?

  • Innovative Solutions: Cutting-edge therapies designed to meet unmet medical needs.
  • Scientific Excellence: Backed by rigorous research and clinical trials ensuring efficacy and safety.
  • Patient-Centric Approach: Focused on improving patient outcomes and quality of life.
  • Experienced Team: Led by industry experts with a proven track record in pharmaceuticals.
  • Commitment to Growth: Dedicated to expanding our pipeline and advancing healthcare solutions.

Who Should Use NRx Pharmaceuticals, Inc. (NRXP)?

  • Pharmaceutical Students: Explore drug development processes and apply theoretical knowledge to real-world scenarios.
  • Researchers: Utilize advanced models in your studies related to pharmaceutical innovations and therapies.
  • Investors: Evaluate your investment strategies and analyze valuation metrics for NRx Pharmaceuticals stock.
  • Healthcare Analysts: Enhance your analysis with a customizable financial model tailored for the biotech sector.
  • Entrepreneurs: Understand how large pharmaceutical companies like NRx Pharmaceuticals are assessed and valued in the market.

What the Template Contains

  • Pre-Filled Data: Includes NRx Pharmaceuticals' historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze NRx Pharmaceuticals' profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.